Several specialized firms worldwide focus on the synthesis of complex drug APIs, notably Abacavir Sodium sulfate, Abarelix, and Abiraterone. These substances present significant challenges in process development due to their structural sophistication. The producers of these APIs often employ advanced methods and adhere to strict regulatory protocol